Nubeqa Tablet, Film Coated
Product Images NDC 50419-395

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nubeqa (NDC 50419-395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of darolutamide, the active ingredient in NUBEQA. The structure depicts darolutamide's molecular framework including chlorine, nitrogen, oxygen, and other elements arranged in distinct rings and side chains with stereochemical notations.*

FDA Label Image

Plan Meier Curve Metastases Free Survival (Image 02)

A Kaplan-Meier survival curve graph showing Metastasis Free Survival Probability (%) over Months From Randomization, comparing NUBEQA (darolutamide) and placebo groups. The graph includes patient risk numbers over time and marks censored data points. NUBEQA group starts with 955 patients, placebo with 554.*

FDA Label Image

Nubeqa 300 mg Label (Image 03)

NUBEQA 300 mg film-coated tablets label showing the product name and strength, darolutamide as the active ingredient, and the quantity of 120 tablets per bottle. The label includes manufacturer information for Bayer HealthCare Pharmaceuticals Inc. and Orion Corporation, Orion Pharma in Finland. The label features a barcode and instructions referencing storage and usage.*

FDA Label Image

Image 04

A Kaplan-Meier survival curve showing overall survival probability (%) over months from randomization for two groups: NUBEQA (N=955) and placebo (N=554). The solid line represents NUBEQA, the dashed line placebo, with censored data indicated by circles. Below the graph is a table listing the number of patients at risk for each group at various time points up to 60 months.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.